Dr. Martin S. Gizzi, MD

Dr. Gizzi practices at Palisades Medical Center in North Bergen, New Jersey, part of Hackensack Meridian Health.

Dr. Gizzi's NPI, 1174523468, was assigned on July 28, 2005. Dr. Gizzi graduated from University of Miami, Miller School of Medicine in 1985. Dr. Gizzi holds New Jersey license MA58400.

Dr. Gizzi's primary practice is Palisades Medical Center, at 7600 River Rd, North Bergen, NJ 07047 in Hudson County. The practice phone is (201) 854-5000.

Dr. Gizzi's primary practice is Palisades Medical Center in North Bergen, New Jersey, part of Hackensack Meridian Health. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Gizzi to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gizzi practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Gizzi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Gizzi is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Gizzi's licenses on file in 5 states: New Jersey, New York, California, Oregon and Washington.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, mobility impairment, stroke and thoracic spine disorders among the conditions Dr. Gizzi treats.

CMS data shows 178 Medicare services from Dr. Gizzi across 6 procedure codes in 2024, for 93 Medicare patients. Medicare paid $18,080 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Gizzi in 2024. The largest group is 75 to 84, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gizzi's median patient age at 66, with 56% women.

In 2024, Dr. Gizzi wrote 19 Medicare Part D claims. 95% of them were for generic drugs. They cover 5 drugs, with $7,643 in total drug cost. In 2022, CMS named 73 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Gizzi for performance year 2024, reported as part of a group. Dr. Gizzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 44 papers to Dr. Gizzi, published from 2002 to 2022. 2014 was the busiest year, with 4. The most frequent topics are Stroke, Nystagmus, Physiologic and Photic Stimulation. Dr. Gizzi has published most often in Exp Brain Res. Dr. Gizzi's most frequent co-authors are Jawad F. Kirmani, MD, Christine Greiss, DO and William J. Kostis, MD, PhD.

Dmand AI links Dr. Gizzi to 5 clinical trials, 2 of them phase 3 studies. Conditions studied include Ischemic Stroke, Stroke and Cerebral Infarction. Open Payments lists research payments to Dr. Gizzi that name 1 trial.

CMS Open Payments shows 34 general payments to Dr. Gizzi from 14 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,734. It also lists 5 research payments totaling $535 in 2022, naming 1 clinical trial.

Dmand AI lists 11 awards for Dr. Gizzi, most recently America's Top Doctors in 2024.

Dr. Gizzi graduated from University of Miami, Miller School of Medicine in 1985. Dr. Gizzi is a member of AAN, American Neurotology Society and North American Neuro-Ophthalmology Society.

Dr. Gizzi is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.